Last week we reported that a deputy director of China's State Food and Drug Administration, Zhang Jingli, was dismissed. He was put under investigation for “disciplinary violations.”

Now, Zhang Jingli is suspected of alleged bribery involving the U.S. company, Johnson & Johnson, Chinese state-run Xinhua news agency reported on Friday.

Zhang assumed his post at the drug agency in 2003. He was apparently dismissed when authorities started investigating possible bribery by drug firms—including the Shanghai-based Johnson & Johnson Medical.

According to the state media report, six other officials of the State Food and Drug Administration are also under investigation.

In 2007, the previous head of the drug agency, Zheng Xiaoyu, was executed for taking bribes to approve unsafe medicine.